Dr Carolien van de Sandt completed her PhD in 2016 at the Erasmus University in Rotterdam (Netherlands) where she investigated the longevity, cross-reactivity and immune evasion strategies of influenza-specific CD8+ T-cells, followed by two years of postdoctoral research. In 2018, she joined the Kedzierska Laboratory as a MSCA Research Fellow to study the mechanisms that underly gain-and-loss-of CD8+ T-cell function across the human lifespan. In 2020, she temporally relocated to Sanquin Research (Netherlands) to study SARS-CoV-2 immunity in autoimmune patients, where she still holds an honorary position. In 2022 she was awarded the ARC-DECRA fellowship to continue her Aging Immunity and T-Cell Development research at the Doherty Institute (University of Melbourne).
